Pharmaxis pulmonary, diagnostic news

PXS formed a subsidiary to conduct the company's clinical and regulatory activities in the U.S. Next quarter, PXS plans to start two U.S. Phase III trials of Bronchitol mannitol to treat cystic fibrosis (CF) and to submit an NDA to FDA for Aridol mannitol powder inhalation test to diagnose asthma. ...